Evidence map›Paper›PMID 30961636›Full record

ArticleMalaria journal2019

Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?

Daniel Camprubí, Arturo Pereira, Natalia Rodriguez-Valero, Alex Almuedo, Rosauro Varo, Climent Casals-Pascual, Quique Bassat, Denis Malvy, Jose Muñoz

Abstract readCase ReportsLetter
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Post-Artesunate Delayed Hemolysis: A Review of Current Evidence.Tropical medicine and infectious disease · 2023
    Review
  10. Article
  11. Article
  12. A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel CamprubíISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. dcamprub@clinic.cat.ORCID http://orcid.org/0000-0003-4215-6030
Arturo PereiraHematology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Natalia Rodriguez-ValeroISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Alex AlmuedoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Rosauro VaroISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Climent Casals-PascualMicrobiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Quique BassatISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Denis MalvyTravel Clinics and Tropical Diseases Unit, University Hospital Center of Bordeaux, Bordeaux, France.
Jose MuñozISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelayed haemolysis is a frequent adverse event after treatment with artesunate (AS). Removing once-infected "pitted" erythrocytes by the spleen is the most accepted mechanism of haemolysis in these cases. However, an increasing number of cases with positive direct antiglobulin test (DAT) haemolysis after AS have been reported.

methodsAll malaria cases seen at Hospital Clinic of Barcelona between 2015 and 2017 were retrospectively reviewed. Clinical, parasitological and laboratory data from patients treated with intravenous artesunate-specifically looking for delayed haemolysis and DAT-was collected.

resultsAmong the 36 severe malaria patients treated with artesunate at the hospital, 10 (27.8%) developed post-artesunate delayed haemolysis. Out of these, DAT was performed in six, being positive in four of them (at least 40%). DAT was positive only for complement-without IgG-suggesting drug-dependent immune-haemolytic anaemia of the immune-complex type. Three of the four patients were treated with corticosteroids and two also received blood transfusion, with a complete recovery.

conclusionsDrug-induced auto-immune phenomena in post-artesunate delayed haemolysis may be underreported and must be considered. The role of corticosteroids should be reassessed.

Indexed as

Administration, IntravenousAdolescentAdultAnemia, HemolyticAntimalarialsArtesunateCoombs TestFemaleHemolysisHumansMalariaMaleMiddle AgedRetrospective StudiesSpainAntimalarialsArtesunateArtesunateCorticosteroidsDirect antiglobulin testHaemolytic anaemiaMalariaPADH

Identifiers

PMID30961636
PMCPMC6454619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.